Difference in the response of neu and ras oncogene-induced rat mammary carcinomas to early and late ovariectomy
- PMID: 1353410
Difference in the response of neu and ras oncogene-induced rat mammary carcinomas to early and late ovariectomy
Abstract
Rat mammary carcinomas were induced by directly inserting activated neu or ras genes into in situ rat mammary ductal cells using replication-defective retroviral vectors. neu was over 200 times more potent than ras in inducing rat mammary carcinomas. Ovariectomy 2 days postinfection dramatically reduced the occurrence of carcinomas induced by neu and extended their latency. In general, early ovariectomy had much less effect on the occurrence of carcinomas induced by ras and had no significant effect on their latency. Carcinomas induced by neu in ovariectomized rats had down-regulated estrogen receptor and progesterone receptor, while those induced by ras had only down-regulated progesterone receptor. Fully progressed mammary carcinomas in intact rats induced by both neu and ras had a similar response to ovariectomy, with an approximate regression rate of 60%. These data suggest that the activation of ras, but not neu, can replace at least some functions performed by ovarian hormones in the early phases of mammary carcinogenesis. These data also suggest a role for antiestrogen drug therapy in the prevention of neu-associated breast cancer.
Similar articles
-
Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.Anticancer Res. 1994 Mar-Apr;14(2A):481-7. Anticancer Res. 1994. PMID: 7912494
-
Carcinoma induction following direct in situ transfer of v-Ha-ras into rat mammary epithelial cells using replication-defective retrovirus vectors.Cancer Res. 1991 May 15;51(10):2642-8. Cancer Res. 1991. PMID: 2021942
-
Frequent induction of mammary carcinomas following neu oncogene transfer into in situ mammary epithelial cells of susceptible and resistant rat strains.Cancer Res. 1991 Oct 15;51(20):5649-54. Cancer Res. 1991. PMID: 1913683
-
The introduction of activated oncogenes to mammary cells in vivo using retroviral vectors: a new model for the chemoprevention of premalignant and malignant lesions of the breast.J Cell Biochem Suppl. 1993;17G:66-72. doi: 10.1002/jcb.240531113. J Cell Biochem Suppl. 1993. PMID: 8007712 Review.
-
Oncogenes and oncoproteins in occupational carcinogenesis.Scand J Work Environ Health. 1992;18 Suppl 1:27-30. Scand J Work Environ Health. 1992. PMID: 1357742 Review.
Cited by
-
How can grafted breast cancer models be optimized?Cancer Biol Ther. 2011 Nov 15;12(10):855-64. doi: 10.4161/cbt.12.10.18139. Epub 2011 Nov 15. Cancer Biol Ther. 2011. PMID: 22057217 Free PMC article. Review.
-
Short-term PI3K Inhibition Prevents Breast Cancer in Preclinical Models.Cancer Prev Res (Phila). 2023 Feb 6;16(2):65-73. doi: 10.1158/1940-6207.CAPR-22-0275. Cancer Prev Res (Phila). 2023. PMID: 36343340 Free PMC article.
-
Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors.Am J Pathol. 1996 Feb;148(2):549-58. Am J Pathol. 1996. PMID: 8579117 Free PMC article.
-
Advances in Rodent Models for Breast Cancer Formation, Progression, and Therapeutic Testing.Front Oncol. 2021 Mar 26;11:593337. doi: 10.3389/fonc.2021.593337. eCollection 2021. Front Oncol. 2021. PMID: 33842308 Free PMC article. Review.
-
Mammary carcinomas induced in human c-Ha-ras proto-oncogene transgenic rats are estrogen-independent, but responsive to d-limonene treatment.Jpn J Cancer Res. 2002 Jan;93(1):32-5. doi: 10.1111/j.1349-7006.2002.tb01197.x. Jpn J Cancer Res. 2002. PMID: 11802805 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous